EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss

Noelle C Garbaccio, Jade E Smith, Agustin Posso, Dorien I Schonebaum, Lacey Foster, Justin J Cordero, Jose Foppiani, Angelica Hernandez Alvarez, Umar Choudry, Samuel J Lin

Aesthetic Plastic Surgery · 2025-11 · 49 (21) · 6078-6088

DOI: 10.1007/s00266-025-05112-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 20.08.2025. Verfasst von Noelle C Garbaccio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Boston, MA, 02215, US…. Hauptthemen laut MEDLINE: Weight Loss, Glucagon-Like Peptides, Body Contouring. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many patients seek body contouring surgery (BCS) to address excess skin following significant weight loss (WL), including from GLP-1 receptor agonists such as semaglutide. Optimal BCS timing is crucial, as postoperative weight fluctuations can distort outcomes. While weight stabilizes 12-18 months after bariatric surgery, the timeline for semaglutide-associated WL is less clear, particularly with weight recurrence (WR) after drug discontinuation METHODS: A systematic review of MEDLINE, Embase, Web of Science, and PubMed was performed. Randomized controlled trials (RCTs) and prospective observational studies measuring weight change over time with semaglutide use were included. Time to weight loss plateau (WLP), defined as ≥1 month with WL

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossGlucagon-Like PeptidesBody ContouringHumansTreatment OutcomeTime FactorsFemaleMaleBariatric SurgeryRisk AssessmentRandomized Controlled Trials as TopicAdultMiddle AgedObesity, MorbidGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

Body contouringGLP-1OzempicSemaglutideTimingWeight

Substanzen

Glucagon-Like PeptidesGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Boston, MA, 02215, USA. noelle.garbaccio@gmail.com.
  • Department of Plastic and Reconstructive Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Boston, MA, 02215, USA. jadesmith34@gmail.com.
  • Department of Plastic and Reconstructive Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Boston, MA, 02215, USA.
  • Department of Plastic and Reconstructive Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Department of Plastic and Reconstructive Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Boston, MA, 02215, USA. sjlin@bidmc.harvard.edu.

Zitieren

APA

Garbaccio, N. C., Smith, J. E., Posso, A., Schonebaum, D. I., Foster, L., Cordero, J. J., Foppiani, J., Alvarez, A. H., Choudry, U., & Lin, S. J. (2025). Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss. Aesthetic Plastic Surgery, 49(21), 6078-6088. https://doi.org/10.1007/s00266-025-05112-3

Vancouver

Garbaccio NC, Smith JE, Posso A, Schonebaum DI, Foster L, Cordero JJ, et al. Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss. Aesthetic Plastic Surgery. 2025;49(21):6078-6088. doi:10.1007/s00266-025-05112-3

BibTeX
@article{Garbaccio2025,
  author = {Garbaccio, Noelle C and Smith, Jade E and Posso, Agustin and Schonebaum, Dorien I and Foster, Lacey and Cordero, Justin J and Foppiani, Jose and Alvarez, Angelica Hernandez and Choudry, Umar and Lin, Samuel J},
  title = {Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  volume = {49},
  number = {21},
  pages = {6078--6088},
  doi = {10.1007/s00266-025-05112-3}
}
Kostenlos starten →